December 2018

Beard KR, Brendish NJ, Clark TW. Treatment of influenza with neuraminidase inhibitors. Curr Opin Infect Dis. 2018 Dec;31(6):514-519.
Abstract

Beigel JH. Polyclonal and monoclonal antibodies for the treatment of influenza. Curr Opin Infect Dis. 2018 Dec;31(6):527-534.
Abstract

Bischoff WE. et al. How well do N95 respirators protect healthcare providers against aerosolized influenza virus? Infect Control Hosp Epidemiol. 2018 Dec 18:1-3.
Abstract

Chang C, Ramphul K. Amantadine [Internet].
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018-.
2018 Dec 5.
Full text

Chong Y. et al. Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan. Influenza Other Respir Viruses. 2018 Dec 11.
Full text

Ciabattini A. et al. Vaccination in the elderly: The challenge of immune changes with aging. Semin Immunol. 2018 Dec;40:83-94.
Full text

Flaherty GT. Getting to the heart of influenza vaccination in winter travelers. J Travel Med. 2018 Dec 24.
Excerpt

France G. Potential Cost-Effectiveness of a Universal Influenza Vaccine in Older Adults. Innov Aging. 2018 Dec 14;2(3):igy035.
Full text

GBD 2017 Influenza Collaborators. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2019 Jan;7(1):69-89.
Full text

Goscé L, Johansson A. Analysing the link between public transport use and airborne transmission: mobility and contagion in the London underground. Environ Health. 2018 Dec 4;17(1):84.
Full text

Hu CJ. et al. Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection. Int J Nanomedicine. 2018 Dec 14;13:8579-8593.
Full text

Huhtinen E. et al. Understanding barriers to effective management of influenza outbreaks by residential aged care facilities. Australas J Ageing. 2018 Dec 10.
Abstract

Jang H, Kim JH. Factors affecting influenza vaccination in adults aged 50-64 years with high-risk chronic diseases in South Korea. Hum Vaccin Immunother. 2018 Dec 14.
Abstract

Jin CN, Tang LL. Muscle weakness associated with H7N9 infection: report of two cases. BMC Infect Dis. 2018 Dec 20;18(1):685.
Full text

Klugman KP. et al. The role of bacterial vaccines in the prevention of influenza mortality. Lancet Glob Health. 2018 Dec;6(12):e1268-e1269.
Full text

Koshimichi H. et al. Population Pharmacokinetic and Exposure-Response Analyses of Baloxavir Marboxil in Adults and Adolescents Including Patients With Influenza. J Pharm Sci. 2018 Dec 15. pii: S0022-3549(18)30800-1.
Full text

Lee N, Hurt AC. Neuraminidase inhibitor resistance in influenza: a clinical perspective. Curr Opin Infect Dis. 2018 Dec;31(6):520-526.
Abstract

Li Y. et al. Closure of live bird markets leads to the spread of H7N9 influenza in China. PLoS One. 2018 Dec 12;13(12):e0208884.
Full text

Ma MJ, Yang Y, Fang LQ. Highly Pathogenic Avian H7N9 Influenza Viruses: Recent Challenges. Trends Microbiol. 2018 Dec 12. pii: S0966-842X(18)30258-0.
Abstract

Maguire PA, Reay RE, Looi JC. Nothing to sneeze at - uptake of protective measures against an influenza pandemic by people with schizophrenia: willingness and perceived barriers. Australas Psychiatry. 2018 Dec 3:1039856218815748.
Abstract

Meng ZY. et al. Immunogenicity of inacitivated quadrivalent influenza vaccine in adults aged 18-64 years: A systematic review and Meta-analysis.[Article in Chinese; Abstract in English] Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Dec 10;39(12):1636-1641.
Full text

Ng TWY. et al. Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis. J Infect Dis. 2018 Dec 14.
Abstract

Pawestri HA. et al. Detection of neuraminidase inhibitor-resistant influenza A (H1N1)pdm09 viruses obtained from influenza surveillance in Indonesia. SAGE Open Med. 2018 Dec 10;6:2050312118818293.
Full text

Pepin S. et al. Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres. Vaccine. 2018 Dec 14. pii: S0264-410X(18)31637-2
Full text

Regan AK. et al. Estimating influenza vaccine effectiveness using data routinely available in electronic primary care records. Vaccine. 2018 Dec 29. pii: S0264-410X(18)31651-7.
Abstract

Sullivan SG, Cowling BJ. Reconciling estimates of the global influenza burden. Lancet Respir Med. 2019 Jan;7(1):8-9.
Full text

Summers JA, Baker M, Wilson N. New Zealand's experience of the 1918-19 influenza pandemic: a systematic review after 100 years. N Z Med J. 2018 Dec 14;131(1487):54-69.
Abstract

Tahir MF. et al. Seroprevalence and risk factors of avian influenza H9 virus among poultry professionals in Rawalpindi, Pakistan. J Infect Public Health. 2018 Dec 18. pii: S1876-0341(18)30319-8.
Full text

Wu T, Perrings C. The live poultry trade and the spread of highly pathogenic avian influenza: Regional differences between Europe, West Africa, and Southeast Asia. PLoS One. 2018 Dec 19;13(12):e0208197.
Full text

Yoo BW. et al. Phase 4, Post-Marketing Safety Surveillance of the MF59-Adjuvanted Influenza Vaccines FLUAD® and VANTAFLU® in South Korean Subjects Aged ≥65 Years. Infect Chemother. 2018 Dec;50(4):301-310.
Full text

Yoshihara K. et al. Influenza B associated Paediatric Acute Respiratory Infection Hospitalization in Central Vietnam. Influenza Other Respir Viruses. 2018 Dec 21.
Full text

Zachreson C. et al. Urbanization affects peak timing, prevalence, and bimodality of influenza pandemics in Australia: Results of a census-calibrated model. Sci Adv. 2018 Dec 12;4(12):eaau5294.
Full text

November 2018

APACI Nov articles
Andrew MK. et al. Influenza Vaccination in Older Adults: Recent Innovations and Practical Applications. Drugs Aging. 2018 Nov 9.
Abstract

Arima A. et al. Selective detections of single-viruses using solid-state nanopores. Sci Rep. 2018 Nov 2;8(1):16305.
Full text

Brickley EB. et al. The effect of pre-existing immunity on virus detection and immune responses in a phase II randomized trial of a Russian-backbone live attenuated influenza vaccine in Bangladeshi children. Clin Infect Dis. 2018 Nov 27.
Abstract

Bui CM. et al. Characterising routes of H5N1 and H7N9 spread in China using Bayesian phylogeographical analysis. Emerg Microbes Infect. 2018 Nov 21;7(1):184.
Full text

Caini S. et al. Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: A systematic literature review. Influenza Other Respir Viruses. 2018 Nov;12(6):780-792.
Full text

Camous X. et al. Healthy elderly Singaporeans show no age-related humoral hyporesponsiveness nor diminished plasmablast generation in response to influenza vaccine. Immun Ageing. 2018 Nov 12;15:28.
Full text

Chaimayo C. et al. Specificity and functional interplay between influenza virus PA-X and NS1 shutoff activity. PLoS Pathog. 2018 Nov 29;14(11):e1007465.
Full text

Chen C. et al. Broad neutralizing activity of a human monoclonal antibody against H7N9 strains from 2013 to 2017. Emerg Microbes Infect. 2018 Nov 14;7(1):179.
Full text

Chen T. et al. Association between rs12252 and influenza susceptibility and severity: an updated meta-analysis. Epidemiol Infect. 2018 Nov 13:1-9.
Abstract

Choudhary ML. et al. Association of Single Nucleotide Polymorphisms in TNFA and IL10 Genes with Disease Severity in Influenza A/H1N1pdm09 Virus Infections: A Study from Western India. Viral Immunol. 2018 Nov 28.
Abstract

Deng L, Wang BZ. A Perspective on Nanoparticle Universal Influenza Vaccines. ACS Infect Dis. 2018 Nov 15.
Abstract

Elbahesh H. et al. Broadly protective influenza vaccines: design and production platforms. Curr Opin Virol. 2018 Nov 26;34:1-9.
Abstract

Feng LZ. Technical guidelines for seasonal influenza vaccination in China (2018-2019). [Article in Chinese;] Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Nov 6;52(11):1101-1114.
Abstract

Feng S. et al. Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study. Lancet Respir Med. 2018 Nov 12. pii: S2213-2600(18)30419-3.
Abstract

Guo Q. et al. The effects of meteorological factors on influenza among children in Guangzhou, China. Influenza Other Respir Viruses. 2018 Nov 8.
Full text

Huang KA. et al. Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans. Nat Microbiol. 2018 Nov 26. doi: 10.1038/s41564-018-0303-7.
Abstract

Kang HR. et al. Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study. J Antimicrob Chemother. 2018 Nov 12.
Abstract

Kikuchi T, Watanabe A. Baloxavir heralds a new era in influenza virus biology. Respir Investig. 2018 Nov 2. pii: S2212-5345(18)30189-8.
Abstract

Kwok KO. et al. Multi-centre study on cultural dimensions and perceived attitudes of nurses towards influenza vaccination uptake. J Hosp Infect. 2018 Nov 27. pii: S0195-6701(18)30672-8.
Abstract

Lao JH. et al. Influence of diurnal temperature range on influenza incidence in the elderly. Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Nov 10;39(11):1454-1458. [Article in Chinese]
Abstract

Li T. et al. Rescue of four pediatric patients with severe influenza A (H3N2) in Weifang, China. J Int Med Res. 2018 Nov;46(11):4800-4805.
Full text

McHugh L. et al. The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study. Clin Infect Dis. 2018 Nov 23. doi: 10.1093/cid/ciy517.
Abstract

Muscatello DJ. Redefining influenza seasonality at a global scale and aligning it to the influenza vaccine manufacturing cycle: a descriptive time series analysis. J Infect. 2018 Nov 23. pii: S0163-4453(18)30309-8.
Abstract

Tsedenbal N. et al. Influenza B viruses circulated during last 5 years in Mongolia. PLoS One. 2018 Nov 15;13(11):e0206987.
Full text

Tuckerman J. et al. Influenza vaccination: Uptake and associations in a cross-sectional study of children with special risk medical conditions. Vaccine. 2018 Dec 18;36(52):8138-8147.
Abstract

Yao KH. Some thoughts on influenza vaccine and regular influenza vaccination for healthcare workers. [Article in Chinese] Zhongguo Dang Dai Er Ke Za Zhi. 2018 Nov;20(11):881-886.
Abstract

Zeng X. et al. Vaccination of poultry successfully eliminated human infection with H7N9 virus in China. Sci China Life Sci. 2018 Nov 7.
Abstract

Zhang CQ. et al. Promoting influenza prevention for elderly people in Hong Kong using health action process approach: study protocol. BMC Public Health. 2018 Nov 6;18(1):1230.
Full text

Zhang Y. et al. Hospitalizations for Influenza-Associated Severe Acute Respiratory Infection, Beijing, China, 2014-2016. Emerg Infect Dis. 2018 Nov;24(11):2098-2102.
Full text

Zhao H. et al. A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines. PLoS One. 2018 Nov 15;13(11):e0207431.
Full text 

October 2018

Althouse BM. et al. Seasonality of respiratory viruses causing hospitalizations for acute respiratory infections in children in Nha Trang, Vietnam. Int J Infect Dis. 2018 Oct;75:18-25.
Full text

Barr IG. et al. Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness. (Australia) NPJ Vaccines. 2018 Oct 9;3:44.
Full text

Benam KH, Denney L, Ho LP. How the Respiratory Epithelium Senses and Reacts to Influenza Virus. Am J Respir Cell Mol Biol. 2018 Oct 29.
Full text

Borg K. et al. Communication-based interventions for increasing influenza vaccination rates among Aboriginal children: A randomised controlled trial. (Australia),Vaccine. 2018 Oct 29;36(45):6790-6795.
Abstract

Burt S, Hattingh L, Czarniak P. Evaluation of patient satisfaction and experience towards pharmacist-administered vaccination services in Western Australia. Int J Clin Pharm. 2018 Oct 26.
Abstract

Byrne-Nash RT. et al. VaxArray potency assay for rapid assessment of "pandemic" influenza vaccines. NPJ Vaccines. 2018 Oct 8;3:43.
Full text

Chan MC. et al. Indirubin-3'-oxime as an antiviral and immunomodulatory agent in treatment of severe human influenza virus infection. Hong Kong Med J. 2018 Oct;24 Suppl 6(5):45-47.
Full text

Chan MCW. et al. Frequent Genetic Mismatch between Vaccine Strains and Circulating Seasonal Influenza Viruses, Hong Kong, China, 1996-2012. Emerg Infect Dis. 2018 Oct;24(10):1825-1834.
Full text

Cheng LP. et al. Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors. Bioorg Med Chem Lett. 2018 Oct 26. pii: S0960-894X(18)30843-6.
Abstract

Chua GT. et al. Hong Kong Institute of Allergy and Hong Kong Society for Paediatric Immunology Allergy & Infectious Diseases joint consensus statement 2018 on vaccination in egg-allergic patients. Hong Kong Med J. 2018 Oct;24(5):527-531.
Full text

Cowling BJ, Chan KH, Peiris JS. Influenza-like illness and viral aetiology in Hong Kong children. Hong Kong Med J. 2018 Oct;24 Suppl 6(5):12-15.
Full text

Drolet M. et al. Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. Value Health. 2018 Oct;21(10):1250-1258.
Full text

Fukuta H. et al. The effect of influenza vaccination on mortality and hospitalization in patients with heart failure: a systematic review and meta-analysis. Heart Fail Rev. 2018 Oct 26.
Abstract

Giles ML. The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review. Hum Vaccin Immunother. 2018 Oct 31.
Abstract

Goldhill DH. et al. The mechanism of resistance to favipiravir in influenza. Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):11613-11618. Epub 2018 Oct 23.
Full text

Hatta M. et al. Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus. Emerg Infect Dis. 2018 Oct;24(10):1910-1913.
Full text

Hayashi T. et al. Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort. Vaccine. 2018 Oct 29;36(45):6650-6659.
Abstract

Koshimichi H. et al. Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings. Clin Drug Investig. 2018 Oct 4.
Full text

Kyaw WM. et al. Factors influencing seasonal influenza vaccination uptake among health care workers in an adult tertiary care hospital in Singapore: A cross-sectional survey. Am J Infect Control. 2018 Oct 4. pii: S0196-6553(18)30838-1.
Abstract

Lau JTF. et al. Low coverage of influenza vaccination among Chinese children aged 12-23 months: Prevalence and associated factors. PLoS One. 2018 Oct 10;13(10):e0205561.
Full text

Le T. et al. Fatal Avian Influenza A/H5N1 Infection in a 36-Week Pregnant Woman Survived by her Newborn - Soc Trang, Vietnam, 2012. Influenza Other Respir Viruses. 2018 Oct 6.

Lee VY. et al. The effect of exercise on local and systemic adverse reactions after vaccinations - Outcomes of two randomized controlled trials. Vaccine. 2018 Oct 6. pii: S0264-410X(18)31345-8.
Abstract

Leung TF. et al. Surveillance of human- and swine-origin influenza in Hong Kong children. Hong Kong Med J. 2018 Oct;24 Suppl 6(5):16-18.
Full text

Leung TF. et al. Influenza surveillance and vaccination in Hong Kong children. Hong Kong Med J. 2018 Oct;24 Suppl 6(5):8-11.
Full text

Liu XX. et al. Effects of air pollutants on occurrences of influenza-like illness and laboratory-confirmed influenza in Hefei, China. Int J Biometeorol. 2018 Oct 31.
Abstract

Lu J. et al. Molecular Evolution, Diversity, and Adaptation of Influenza A(H7N9) Viruses in China. Emerg Infect Dis. 2018 Oct;24(10):1795-1805.
Full text

Mak DB. et al. Antenatal influenza and pertussis vaccination in Western Australia: a cross-sectional survey of vaccine uptake and influencing factors. BMC Pregnancy Childbirth. 2018 Oct 24;18(1):416.
Full text

Mifsud EJ. et al. Animal models used to assess influenza antivirals. Expert Opin Drug Discov. 2018 Oct 26:1-9.
Abstract

Mo PKH, Wong CHW, Lam EHK. Can the Health Belief Model and moral responsibility explain Influenza vaccination uptake among nurses? J Adv Nurs. 2018 Oct 30.
Abstract

Morishima M, Kishida K. Understanding attitudes toward hygiene mask use in Japanese daily life by using a repeated cross-sectional survey. Work. 2018 Oct 23.
Abstract

Pillsbury AJ. et al. Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia. BMJ Open. 2018 Oct 18;8(10):e023263.
Full text

Schaffner W. et al. Seasonal influenza immunisation: Strategies for older adults. Int J Clin Pract. 2018 Oct;72(10):e13249.
Abstract

Short KR, Kedzierska K, van de Sandt CE. Back to the Future: Lessons Learned From the 1918 Influenza Pandemic. Front Cell Infect Microbiol. 2018 Oct 8;8:343.
Full text

Thang HV. et al. Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam. Vaccine. 2018 Oct 15. pii: S0264-410X(18)31365-3.
Abstract

Tian C. et al. Characteristics associated with influenza vaccination uptake among adults. J Public Health (Oxf). 2018 Oct 20.
Abstract

Wang Q. et al. Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis. Vaccine. 2018 Oct 16. pii: S0264-410X(18)31411-7.
Abstract

Wang Y. et al. Universal influenza vaccines: from viruses to nanoparticles. Expert Rev Vaccines. 2018 Oct 26:1-10.
Abstract

Wei X, Cui J. Why were so few people infected with H7N9 influenza A viruses in China from late 2017 to 2018? Sci China Life Sci. 2018 Oct 23.
Preview

Weibel D. et al. Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment. Vaccine. 2018 Oct 1;36(41):6202-6211.
Full text

Yang L. et al. Estimation of excess mortality and hospitalisation associated with the 2009 pandemic influenza. Hong Kong Med J. 2018 Oct;24 Suppl 6(5):19-22.
Full text

Young B. et al. Six-monthly versus annual influenza vaccination in older adults in the tropics: an observer-blind, active-comparator controlled, randomised superiority trial. Clin Infect Dis. 2018 Oct 1.
Abstract 

September 2018

Davidson S. Treating Influenza Infection, From Now and Into the Future. Front Immunol. 2018 Sep 10;9:1946.
Full text

Donzelli A. Influenza Vaccinations for All Pregnant Women? Better Evidence Is Needed. Int J Environ Res Public Health. 2018 Sep 18;15(9). pii: E2034
Full text

Ellebedy AH. Immunizing the Immune: Can We Overcome Influenza's Most Formidable Challenge? Vaccines (Basel). 2018 Sep 22;6(4). pii: E68.
Full text

Fox A, Quinn KM, Subbarao K. Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine. Drugs. 2018 Sep;78(13):1297-1308.
Abstract

GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018 Sep 19. pii: S1473-3099(18)30310-4.
Full text

Hayden FG. et al. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. N Engl J Med. 2018 Sep 6;379(10):913-923.
Abstract

Huang W. et al. Neuraminidase inhibitor susceptibility profile of human influenza viruses during the 2016-2017 influenza season in Mainland China. J Infect Chemother. 2018 Sep;24(9):729-733.
Abstract

Ikematsu H. et al. Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate in the 2016/17 Japanese influenza season; comparison with the 2011/12 to 2015/16 seasons. J Infect Chemother. 2018 Sep;24(9):718-724.
Full text

Kang YK. et al. Evaluation of the field-protective effectiveness of seasonal influenza vaccine among Korean children aged < 5 years during the 2014-2015 and 2015-2016 influenza seasons: a cohort study. Hum Vaccin Immunother. 2018 Sep 27.
Abstract

Kao KC. et al. Predictors of survival in patients with influenza pneumonia-related severe acute respiratory distress syndrome treated with prone positioning. Ann Intensive Care. 2018 Sep 24;8(1):94.
Full text

Kawaguchi N. et al. Evaluation of Drug-Drug Interaction Potential between Baloxavir Marboxil and Oseltamivir in Healthy Subjects. Clin Drug Investig. 2018 Sep 10.
Full text

Kim YK. et al. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea. Pharmacoeconomics. 2018 Sep 25.
Full text

Looi QH. et al. How far have we reached in development of effective influenza vaccine? Int Rev Immunol. 2018 Sep 25:1-11.
Abstract

Mertz L. Vaccination Innovation: New Technologies Are Leading the Way to Vaccines That Work Better, Hurt Less. IEEE Pulse. 2018 Sep-Oct;9(5):25-30.
Abstract

Meyer D. et al. Taiwan's Annual Seasonal Influenza Mass Vaccination Program-Lessons for Pandemic Planning. Am J Public Health. 2018 Sep;108(S3):S188-S193.
Full text

Ogasawara K. The long-run effects of pandemic influenza on the development of children from elite backgrounds: Evidence from industrializing Japan. Econ Hum Biol. 2018 Sep 1;31:125-137.
Abstract

Ortiz JR, Hombach J. Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines. Vaccine. 2018 Sep 5;36(37):5504-5505.
Full text

Reiman JM. et al. Humidity as a non-pharmaceutical intervention for influenza A. PLoS One. 2018 Sep 25;13(9):e0204337.
Full text

Sam IC. et al. Seasonal influenza activity based on laboratory surveillance in Malaysia, 2011-2016. J Med Virol. 2018 Sep 10.
Abstract

Tam YH. et al. The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17. Vaccine. 2018 Oct 1;36(41):6117-6123.
Abstract

Tan M. et al. Saliva as a source of reagent to study human susceptibility to avian influenza H7N9 virus infection. Emerg Microbes Infect. 2018 Sep 19;7(1):156.
Full text

Wen F, Guo J, Huang S. A meta-analysis identified genes responsible for distinct immune responses to trivalent inactivated and live attenuated influenza vaccines. J Cell Physiol. 2018 Sep 10.
Abstract

Wu S. et al. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season. Vaccine. 2018 Sep 11;36(38):5774-5780.
Abstract

Zhu W, Yang L, Shu Y. Did the Highly Pathogenic Avian Influenza A(H7N9) Viruses Emerged in China Raise Increased Threat to Public Health? Vector Borne Zoonotic Dis. 2018 Sep 15.
Abstract